Emerging Tech Investing Ocumetics Engages The Howard Group to Direct Capital Market & Corporate Digital Communications Programs
Emerging Tech Investing Ocumetics Prepares for a Second Day of Accommodating Intraocular Lens Implantations
Ocumetics Announces Completion of First Tranche of Debenture Private Placement for Net Proceeds of CA$2.82 Million
life science investing Ocumetics Continues to Meet Significant Development Milestones; Lens Design Optimized for Upcoming First in Human Study
life science investing Ocumetics Welcomes Dr. Doyle Stulting and Dr. Bart McRoberts to Board of Directors
